Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 68788-4193

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68788-4193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5061f4f1 32fe 4ab4 8787 E054053108d0 01)

Chemical structure diagram of divalproex sodium showing the molecular arrangement including sodium ion and proton components, representing the extended-release molecule.*

FDA Label Image

Image (5061f4f1 32fe 4ab4 8787 E054053108d0 02)

A line graph comparing percentage reduction in CPS rate between divalproex sodium delayed-release tablets and placebo across a patient population. The x-axis shows percentage of patients, and the y-axis shows percent reduction in CPS rate, indicating improvement or worsening. The graph includes two curves, one solid for divalproex sodium and one dashed for placebo.*

FDA Label Image

Image (5061f4f1 32fe 4ab4 8787 E054053108d0 03)

A line graph showing the percentage reduction in CPS rate plotted against the percentage of patients for high dose and low dose divalproex sodium delayed-release tablets. The vertical axis indicates improvement or worsening in CPS rate, while the horizontal axis represents the percentage of patients, highlighting comparative treatment effects.*

FDA Label Image

Image (5061f4f1 32fe 4ab4 8787 E054053108d0 04)

A bar chart comparing the effect of placebo versus divalproex sodium extended-release tablets. The vertical axis ranges from 0 to 1.2, showing a higher value for divalproex sodium (1.2) compared to placebo (0.6). The chart includes a significance indicator with p=0.006.*

FDA Label Image

Logo (5061f4f1 32fe 4ab4 8787 E054053108d0 05)

FDA Label Image

Divalproex Sodium Er Tab 500mg (5061f4f1 32fe 4ab4 8787 E054053108d0 07)

Label for Divalproex Sodium ER Tab 500 mg extended release film-coated oral tablets by Preferred Pharmaceuticals Inc. The label states it is a generic for Depakote ER and contains valproic acid 500 mg. It includes storage instructions, manufacturer (Unichem Laboratories Ltd.), barcode, and boxed directions in English and Spanish with dosage placeholders. Additional labeling areas list batch, lot, and NDC information fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.